YUHOME INTERNATIONAL BIOLOGICAL TECHNOLOGY CO., LTD.
Update：2025/12/03
Industries
Main Industry
Health Care
Main Product/Service
YUHOME is currently focusing on the research and development of supplement for Alzheimer’s disease, dementia, cardiovascular and metabolic diseases.
Founded Year
2013
Unified Business No.
54130563
Status
Active
Number of Employees
0
Total Paid-in
Capital
16,000,000 (NT$)
Location of Company
Taiwan
, Taichung City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Established in 2013, YUHOME is self-motivated to become one of the most innovative bio-medicine companies in the globe. Strontium citrate has been researched and developed for more than 160 years, we dedicate ourselves to develop and produce high-quality, safe and effective supplement for special medical purpose, which can be used for prevention of diseases and postoperative recovery, contributing to improve your quality of life. We use our professional knowledge in technology, improving people’s health and welfare in every stages of life.
